Krystal Biotech annual revenue
2021
2022
2023
2024
2025
Krystal Biotech Revenue Growth & History (KRYS)
Krystal Biotech reported $389.1M in revenue for fiscal 2025, an increase of 33.94% from the previous fiscal year.
View full Krystal Biotech company overviewKrystal Biotech annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $389.1M | $98.6M | +33.94% |
| 2024 | 2024-12-31 | $290.5M | $239.8M | +473.02% |
| 2023 | 2023-12-31 | $50.7M | $50.7M | — |
| 2022 | 2022-12-31 | $0 | $0 | — |
| 2021 | 2021-12-31 | $0 | — | — |
Krystal Biotech quarterly revenue
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $119.2M | $23.2M | +24.14% |
| Q1 2026 | 2026-03-31 | $116.4M | $28.2M | +31.95% |
| Q4 2025 | 2025-12-31 | $107.1M | $16.0M | +17.52% |
| Q3 2025 | 2025-09-30 | $97.8M | $14.0M | +16.65% |
| Q2 2025 | 2025-06-30 | $96.0M | $25.8M | +36.65% |
| Q1 2025 | 2025-03-31 | $88.2M | $42.9M | +94.88% |
| Q4 2024 | 2024-12-31 | $91.1M | $49.0M | +116.26% |
| Q3 2024 | 2024-09-30 | $83.8M | $75.3M | +879.91% |
| Q2 2024 | 2024-06-30 | $70.3M | $70.3M | — |
| Q1 2024 | 2024-03-31 | $45.3M | $45.3M | — |
| Q4 2023 | 2023-12-31 | $42.1M | — | — |
| Q3 2023 | 2023-09-30 | $8.6M | $8.6M | — |
| Q2 2023 | 2023-06-30 | $0 | — | — |
| Q1 2023 | 2023-03-31 | $0 | — | — |
| Q3 2022 | 2022-09-30 | $0 | — | — |
Krystal Biotech revenue growth trends
Krystal Biotech's latest reported quarter, Q2 2026, generated $119.2M in revenue, an increase of 24.14% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Krystal Biotech source filings ↗